| 06:36p | ROCHE : Mexican restaurant, Hungry Coyote, still not open in Needham | AQ |
| 06:19p | TETRA BIO-PHARMA INC : . Announces Proposed Offering of Units | AQ |
| 06:18p | Cronos Group Inc. Announces Results of Vote for Election of Directors | GL |
| 06:08p | SCHOLAR ROCK : Announces Pricing of Public Offering of Common Stock | AQ |
| 06:07p | CANOPY GROWTH : shareholders approve proposed acquisition of Acreage Holdings | AQ |
| 06:01p | QUIDEL : Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel's Triage® MeterPro Instrumented System | BU |
| 05:57p | PATENT APPLICATION TITLED “GRASPING TREATMENT INSTRUMENT” PUBLISHED ONLINE (USPTO 20190159801) : Olympus Corporation | AQ |
| 05:52p | SEDANA MEDICAL ENTERS CHINA - SIGNS WITH CHINESE DISTRIBUTOR : Sedana Medical | AQ |
| 05:42p | FINDINGS FROM GLAXOSMITHKLINE PLC PROVIDES NEW DATA ON BIOPHARMACEUTICALS (THE BIODISTRIBUTION AND CLEARANCE OF ALBUDAB, A NOVEL BIOPHARMACEUTICAL MEDICINE PLATFORM, ASSESSED VIA PET IMAGING IN HUMANS) : Drugs and Therapies - Biopharmaceuticals | AQ |
| 05:41p | AN APPLICATION FOR THE TRADEMARK “PURINETHOL ACCESSPROGRAM (MERCAPTOPURINE)” HAS BEEN FILED BY TEVA PHARMACEUTICALS USA : Teva Pharmaceuticals USA | AQ |
| 05:41p | FINDINGS FROM HEBEI MEDICAL UNIVERSITY UPDATE UNDERSTANDING OF MOLECULAR MEDICINE (KETAMINE DESTABILIZES GROWTH OF DENDRITIC SPINES IN DEVELOPING HIPPOCAMPAL NEURONS IN VITRO VIA A RHO-DEPENDENT MECHANISM) : Health and Medicine - Molecular Medicine | AQ |
| 05:40p | PATENT APPLICATION TITLED “INTRAOCULAR LENS STORAGE CART AND METHODS” PUBLISHED ONLINE (USPTO 20190164112) : Novartis AG | AQ |
| 05:36p | “TRANSDERMAL DRUG DELIVERY APPARATUS AND METHODS” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190160273) : Sorrento Therapeutics Inc. | AQ |
| 05:36p | UPDATE ON OCULOPHARYNGEAL MUSCULAR DYSTROPHY PROGRAM : Benitec Biopharma Limited | AQ |
| 05:35p | RECENT FINDINGS FROM NOVARTIS PHARMA AG PROVIDES NEW INSIGHTS INTO BIOSIMILARS (THE ASSESSMENT OF QUALITY ATTRIBUTES FOR BIOSIMILARS : a Statistical Perspective On Current Practice and a Proposal): Drugs and Therapies - Biosimilars | AQ |
| 05:23p | REGENERON PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 05:23p | ALIMERA SCIENCES INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) | AQ |
| 05:23p | RESTORATION ROBOTICS, INC. : Entry into a Material Definitive Agreement (form 8-K) | AQ |
| 05:20p | PATENT ISSUED FOR PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM (USPTO 10,307,484) : Axsome Therapeutics Inc. | AQ |
| 05:19p | CANOPY GROWTH : announces shareholder approval in connection with the proposed acquisition of Acreage & provides update on American hemp and CBD operations | AQ |
| 05:19p | ROCKWELL MEDICAL, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 05:19p | BIOCEPT INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) | AQ |
| 05:19p | SESEN BIO, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) | AQ |
| 05:19p | ENSIGN GROUP, INC : Other Events (form 8-K) | AQ |
| 05:16p | MUSTANG BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 05:13p | AERPIO PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 05:11p | ADIAL PHARMACEUTICALS, INC. : Shareholder Director Nominations, Other Events (form 8-K) | AQ |
| 05:08p | PATENT ISSUED FOR PROCESS FOR THE PREPARATION OF LORCASERIN HYDROCHLORIDE (USPTO 10,308,611) : Aurobindo Pharma Ltd. | AQ |
| 05:07p | CANNABIS APPROVAL RATINGS ARE ONLY INCREASING IN NORTH AMERICA AGAIN : FinancialNewsMedia.com | AQ |
| 05:06p | PATENT ISSUED FOR HYDROPHILIC IMPRESSION MATERIAL WITH IMPROVED STORAGE STABILITY (USPTO 10,307,345) : Dentsply Sirona Inc. | AQ |
| 05:05p | ACERUS REACHES MUTUAL AGREEMENT WITH INNOVUS PHARMA TO TERMINATE DISTRIBUTION AND LICENSE AGREEMENT FOR URIVARX® IN CANADA : Acerus Pharmaceuticals Corporation | AQ |
| 05:05p | OSMOTICA PHARMACEUTICALS PLC : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 05:04p | MIDATECH PHARMA : Description Report of Foreign Issuer | PU |
| 05:03p | HEDGEPATH PHARMACEUTICALS, INC. : Other Events (form 8-K) | AQ |
| 05:03p | DAVITA INC. : Completion of Acquisition or Disposition of Assets (form 8-K) | AQ |
| 05:03p | ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 05:01p | PATENT ISSUED FOR CONTROL CIRCUIT AND CONTROL METHOD FOR A SYNCHRONOUS MACHINE (USPTO 10,312,840) : Dentsply Sirona Inc. | AQ |
| 04:58p | AN APPLICATION FOR THE TRADEMARK “THERMOFLEX” HAS BEEN FILED BY THERMO FISHER SCIENTIFIC : Thermo Fisher Scientific | AQ |
| 04:56p | ATLAS-PEDS : An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B: DNA Viruses - Hepatitis B Virus | AQ |
| 04:56p | BLUEPRINT MEDICINES' HIGHLY SELECTIVE RET INHIBITOR BLU-667 SHOWS DURABLE ANTI-TUMOR ACTIVITY IN PATIENTS WITH RET-ALTERED CANCERS IN UPDATED ARROW TRIAL DATA PRESENTED AT ASCO 2019 : Blueprint Medicines | AQ |
| 04:56p | CALITHERA BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 04:56p | OPTUM : Completes Acquisition of DaVita Medical Group from DaVita | BU |
| 04:48p | X4 PHARMACEUTICALS, INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) | AQ |
| 04:48p | LIVANOVA : Welcomes Stacy Enxing Seng to Board of Directors | BU |
| 04:46p | NEW CHEMOTHERAPY STUDY RESULTS FROM BRISTOL-MYERS SQUIBB COMPANY DESCRIBED (EXTRACTING DATA FROM A CHEMOTHERAPY PRESCRIPTION PLATFORM FOR REAL-WORLD ONCOLOGY RESEARCH IN THE UK : a pilot study): Drugs and Therapies - Chemotherapy | AQ |
| 04:46p | STUDY FINDINGS FROM APPLIED GENETIC TECHNOLOGIES CORPORATION PROVIDE NEW INSIGHTS INTO GENE THERAPY (TOXICOLOGY AND PHARMACOLOGY OF AN AAV VECTOR EXPRESSING CODON-OPTIMIZED RPGR IN RPGR-DEFICIENT RD9 MICE) : Biotechnology - Gene Therapy | AQ |
| 04:45p | INVACARE CORP : Regulation FD Disclosure (form 8-K) | AQ |
| 04:44p | NORDIC NANOVECTOR : European Patent Granted for Betalutin® or Humalutin® in Combination With Anti-CD20 Antibodies for Treating NHL: Nordic Nanovector | AQ |
| 04:44p | RESHAPE LIFESCIENCES INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) | AQ |
| 04:41p | ROSA TOTAL KNEE INVESTIGATIONAL TESTING AUTHORIZATION STUDY : PROSPECTIVE SINGLE CENTER STUDY OF THE ROSA Total Knee System: Surgery - Arthroplasty | AQ |
United Kingdom
France
Deutschland
Schweiz (DE)
